Introduction

Brain Tumor Drug Development provides a clear, multidisciplinary update on modern therapies for glioblastoma and other aggressive brain tumors. The book focuses on improving drug precision, crossing the blood-brain barrier, identifying biomarkers, designing effective trials, and accelerating translation from research to real patient care.

Key Features

• - Discusses how to overcome the blood-brain barrier using advanced delivery methods.
• - Explains how to improve drug penetration and specificity with nano and polymer-based systems.
• - Explores new therapies through immunotherapy, gene therapy, and personalised medicine.
• - Outlines preclinical models and identifies biomarkers to support clinical success.
• - Details regulatory-aligned clinical trial strategies for faster translation.

Target Readership:

Researchers, clinicians, pharma developers, and graduate students in neuro-oncology, molecular pharmacology, and oncology-focused biotechnology.